Global Pimozide Tablet Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Pimozide Tablet Market Research Report 2024
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-701). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
According to Mr Accuracy reports new survey, global Pimozide Tablet market is projected to reach US$ 2195.5 million in 2029, increasing from US$ 1411 million in 2022, with the CAGR of 6.3% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pimozide Tablet market research.
The Pimozide Tablet market has evolved as a prescription medication used to treat various psychiatric disorders, including schizophrenia and Tourette's syndrome. Pimozide is an antipsychotic medication that helps regulate certain chemicals in the brain to alleviate symptoms such as hallucinations, delusions, and repetitive behaviors. Despite being effective in managing these conditions, its use is limited due to potential side effects and interactions with other medications. As psychiatric treatment advances, the Pimozide Tablet market addresses specific medical needs, offering healthcare professionals a tool to address certain mental health disorders while carefully considering individual patient profiles and potential risks.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pimozide Tablet market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
Segment by Type
1Mg
2Mg
4Mg
Hospitals
Drugstores
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Pimozide Tablet report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Pimozide Tablet market is projected to reach US$ 2195.5 million in 2029, increasing from US$ 1411 million in 2022, with the CAGR of 6.3% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pimozide Tablet market research.
The Pimozide Tablet market has evolved as a prescription medication used to treat various psychiatric disorders, including schizophrenia and Tourette's syndrome. Pimozide is an antipsychotic medication that helps regulate certain chemicals in the brain to alleviate symptoms such as hallucinations, delusions, and repetitive behaviors. Despite being effective in managing these conditions, its use is limited due to potential side effects and interactions with other medications. As psychiatric treatment advances, the Pimozide Tablet market addresses specific medical needs, offering healthcare professionals a tool to address certain mental health disorders while carefully considering individual patient profiles and potential risks.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pimozide Tablet market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
Segment by Type
1Mg
2Mg
4Mg
Segment by Application
Hospitals
Drugstores
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Pimozide Tablet report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices